Conditions: Seasonal Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 426
Healthy volunteers: no

Brief summary:
This study is designed to assess the effectiveness of mometasone furoate nasal spay (MFNS) once daily (QD) compared with placebo in subjects with seasonal allergic rhinitis (SAR) in reducing the total nasal symptom score and the total ocular symptom score.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: mometasone furoate intervention 2: Placebo
Intervention descriptions: intervention 1: 50 mcg/spray, two sprays in each nostril once daily (ie, 200 mcg QD) in the morning intervention 2: Two sprays in each nostril once daily in the morning

Protocol document: